Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori
- 1 January 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (1) , 185-187
- https://doi.org/10.1128/aac.36.1.185
Abstract
The doubling times of bacteria at sites of colonization or infection are considerably longer than those in laboratory culture media, and slow growth reduces the susceptibility of bacteria to antimicrobial agents. Helicobacter pylori is susceptible to a wide range of antimicrobial agents in vitro; however, tests for inhibitory activity do not adequately predict which antimicrobial agents will eradicate slowly growing H. pylori from the stomachs of patients. The chemostat can be used to compare the bactericidal activities of antimicrobial substances against slowly growing bacteria. In this study we compared the bactericidal activities of antimicrobial agents against slowly growing H. pylori. The bactericidal activities of erythromycin, minocycline, ampicillin, amoxicillin, cefixime, metronidazole, and bismuth subcitrate against slowly growing H. pylori NCTC 11,637 in a chemostat were compared. Antimicrobial agents were added to the system at four to eight times the MIC. Exposure of H. pylori to metronidazole was associated with the rapid development of metronidazole resistance, preventing assessment of the bactericidal activity of metronidazole. Resistance to the other antimicrobial agents tested did not develop. The poor bactericidal activities of the antimicrobial agents against slowly growing H. pylori may be a contributory factor in limiting their clinical efficacies. Of the agents tested, only amoxicillin and bismuth subcitrate showed bactericidal activity against slowly growing H. pylori. The chemostat allows comparison of the bactericidal activities of antimicrobial agents against slowly growing H. pylori and may therefore provide results which more accurately identify those agents or combinations of agents that will eradicate H. pylori from patients.Keywords
This publication has 14 references indexed in Scilit:
- Duodenal ulcer: the villain unmasked?BMJ, 1991
- Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapyAntimicrobial Agents and Chemotherapy, 1990
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990
- Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat systemAntimicrobial Agents and Chemotherapy, 1989
- Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Journal of Clinical Pathology, 1988
- Monotherapy or Polychemotherapy in the Treatment ofCampylobacter pylori-Related Gastroduodenal DiseaseScandinavian Journal of Gastroenterology, 1988
- Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural studyJournal of Medical Microbiology, 1987
- Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostatAntimicrobial Agents and Chemotherapy, 1986
- The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridisJournal of Antimicrobial Chemotherapy, 1986
- Comparative Activity of Amoxycillin and Ampicillin in an Experimental Bacterial Infection in MiceAntimicrobial Agents and Chemotherapy, 1973